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Leukocyte migration through activated venular walls is a fundamental immune response that is prerequisite
to the entry of effector cells such as neutrophils, monocytes, and effector T cells to sites of infection, injury,
and stress within the interstitium. Stimulation of leukocytes is instrumental in this process with enhanced
temporally controlled leukocyte adhesiveness and shape-changes promoting leukocyte attachment to the
inner wall of blood vessels under hydrodynamic forces. This initiates polarized motility of leukocytes within
and through venular walls and transient barrier disruption facilitated sequentially by stimulated vascular cells,
i.e., endothelial cells and their associated pericytes. Perivascular cells such as macrophages and mast cells
that act as tissue inflammatory sentinels can also directly and indirectly regulate the exit of leukocytes from
the vascular lumen. In this review, we discuss current knowledge and open questions regarding the mecha-
nisms involved in the interactions of different effector leukocytes with peripheral vessels in extralymphoid
organs.INTRODUCTION
Circulating blood leukocytes are required to migrate to sites of
tissue injury and infection with the principal aim of eliminating
the primary inflammatory trigger and contributing to tissue
repair. In innate immunity, this process is largely initiated by
pathogen-associated molecular patterns (PAMPs), released by
invading microorganisms, and damage-associated molecular
patterns (DAMPs), derived from damaged and/or dead-cells, or
in response to tissue and/or cellular stress (Medzhitov, 2008).
In addition, antigens, largely through activation of resident mem-
ory T cells, can trigger recruitment of leukocytes via secretion of
various primary inflammatory cytokines. Tissue sentinel cells,
including mast cells, macrophages, and dendritic cells (DCs),
play a key role in detection of such danger signals and can
release a wide range of proinflammatory mediators to promote
leukocyte recruitment.
The primary step in leukocyte migration is the establishment of
weak and transient adhesive interactions between leukocytes
and endothelial cells of postcapillary venular walls in close vicin-
ity to inflamed tissues (Figure 1). This facilitates in situ stimulation
of leukocytes by endothelial presented chemoattractants dis-
played on the luminal side of blood vessels, propagating firm
leukocyte arrest, adhesion strengthening, crawling, and subse-
quently migration of cells out of the blood vasculature (reviewed
by [Ley et al., 2007]). This series of sequential but overlapping
steps termed the leukocyte-adhesion cascade, is primarily
mediated by twomajor adhesion receptor families, selectins (ex-
pressed on leukocytes and endothelial cells) and integrins (leu-
kocytes) (reviewed by [Ley et al., 2007]) (Figure 1). Activation of
endothelial cells is a decisive step in this process and can occur
in a rapid and protein-synthesis-independent manner (within mi-
nutes) resulting in cell-surface expression of preformed adhesion
molecules involved in initiating rapid attachment of leukocytes
to blood vessels (e.g., P-selectin). In addition, endothelial cell694 Immunity 41, November 20, 2014 ª2014 Elsevier Inc.activation can occur more slowly (within hours) and involve tran-
scriptional induction of numerous leukocyte-trafficking mole-
cules (primarily endothelial cell selectins, integrin ligands, and
de novo transcribed chemoattractants [reviewed by Pober and
Sessa, 2007]). Rapid activation of endothelial cells can be
induced by inflammatory stimuli such as histamine and PAF
while slow activation can be driven by cytokines (e.g., inter-
leukin-1b [IL-1b] and tumor necrosis factor [TNF]). These modes
of endothelial cell stimulation have been termed type I and type II
activation, respectively (Pober and Sessa, 2007). Shortly after
arresting on their target blood vessel endothelial cells, leuko-
cytes must integrate additional chemotactic cues—primarily
chemokines or lipid chemoattractants (reviewed by [Alon and
Shulman, 2011; Rot and von Andrian, 2004]). These cues govern
the site and route of leukocyte migration along and through the
endothelial cell barrier, determining a potential need for chemo-
tactic crawling on the apical aspect of the endothelium to seek
permissive sites and/or additional exit cues. The latter is sup-
ported by the ability of leukocytes to extend ventral protrusions
through junctions between adjacent endothelial cells or into
the endothelial cell body, facilitating a sensing mechanism for
detection of chemotactic gradients associatedwith the endothe-
lium or in the subendothelial cell space.
Beyond the endothelium, leukocytes are required to traverse
through the pericyte layer embedded within the venular base-
ment membrane, a phase of leukocyte trafficking that can also
involve leukocyte sensitization by tissue-derived inflammatory
signals (Figure 1). The collective breaching of the venular wall
is a highly instructive process during which the transmigrating
leukocytes and both cellular and matrix components of the
vasculature undergo extensive alterations via spatially coordi-
nated bidirectional signaling events details of which have begun
to unfold (reviewed by [Nourshargh et al., 2010]). Most notably,
transmigrated leukocytes exhibit altered phenotype, enhanced
survival, and increased effector functions, such as greater ability
Figure 1. Leukocyte-Vessel Wall Interactions
In response to a diverse range of proinflammatory triggers, released danger signals and other proinflammatory mediators can stimulate leukocytes and vascular
cells to initiate a cascade of leukocyte adhesion and motility responses on the luminal aspect of venular endothelial cells. This enables optimal scanning of the
vascular lumen for exit signals. Leukocyte rolling, firm attachment, and intravascular crawling are sequentially mediated by the indicated endothelial cell adhesion
molecules and leukocyte endothelial selectin and integrin ligands, responses that are prerequisites to leukocyte migration through venular walls. A delicate
balance between integrin-ligand microclusters and actomyosin machineries (inset) allows arrested leukocytes to scan the endothelial lumen for chemotactic exit
signals under hydrodynamic forces. This balance is spatially and temporally regulated by multiple GTPases activated primarily by chemoattractant signals. For
simplicity, initial capturing and fast rolling steps are omitted. More details of the molecular interactions are provided in the text and in Box 1. BM, basement
membrane.
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Reviewto kill and clear invading pathogens and tumor cells. Conse-
quently, breaching of venular walls not only provides a regulated
process for facilitating leukocyte migration into inflamed tissues
but also acts as a key process through which tissue-infiltrated
leukocytes are primed for delivering an effective immune
response (Nourshargh et al., 2010; Stark et al., 2013). Once in
the interstitial tissue, leukocytes can exhibit multiple forms of
leukocyte migration patterns where numerous cellular and
molecular regulatory mechanisms have been proposed (La¨m-
mermann and Germain, 2014; McDonald and Kubes, 2011; We-
ninger et al., 2014). This review will provide a brief outline of
recent advances in our current knowledge of the bidirectional
interactions of effector leukocytes with different vascular beds
followed by a more in-depth discussion of the mechanisms
that regulate leukocyte breaching of postcapillary venules in
nonlymphoid tissues.
Luminal Leukocyte-Vessel Wall Interactions in
Postcapillary Venules
Within the leukocyte-adhesion cascade, each step is condi-
tional on the next (Figure 1) and multiple molecular choices at
each step provide a large combinatorial diversity and high spec-
ificity required for selective leukocyte recruitment at the right
tissue and within the correct context (reviewed by [Ley et al.,
2007]). Integrins constitute a family of about 30 heterodimers
that participate in a wide spectrum of cellular functions and
whose ligand-binding activity is rapidly regulated by cytoskele-
tally controlled conformational changes and mechanical forces,
as well as by redistribution from intracellular pools (Herter andZarbock, 2013). With the exception of effector lymphocytes
and certain monocyte subsets that express adhesive integrins
(Carlin et al., 2013; Lek et al., 2013; Shulman et al., 2012), all
circulating leukocytes maintain their integrins in largely inactive
states. Leukocyte integrins must develop high affinity and
avidity for their specific endothelial ligands in order to establish
firm shear-resistant adhesions (Alon and Dustin, 2007; Carman
and Springer, 2003; Ley et al., 2007). This transition requires
freely flowing leukocytes to be reversibly captured on the endo-
thelium, a step that is mediated by leukocyte glycoprotein (e.g.,
PSGL-1) interactions with members of the selectin family P- and
E-selectin. Selectins can be induced on acutely or chronically
stimulated postcapillary venules (e.g., P-selectin and P- and
E-selectin, respectively), as well as on platelets or platelet
microparticles deposited on injured blood vessels (reviewed
by [Ley et al., 2007; Zarbock et al., 2011]). Free-flowing leuko-
cytes can also interact with attached leukocytes through bind-
ing of leukocyte L-selectin to leukocyte PSGL-1 (Walcheck
et al., 1996).
Selectin-mediated leukocyte rolling is often stabilized by
leukocyte microvilli flattening that slows down the rolling
leukocyte and further enhances the topographical availability
of its chemokine receptors and integrins for interactions with
their respective endothelial ligands (Chen and Springer,
1999). This response is further supported by elongation of
rear tethers as well as by cell autonomous adhesive substrates
termed slings (Sundd et al., 2012). These rolling interactions
increase the efficiency of leukocyte encounters with endothe-
lial cell-expressed chemoattractants (largely chemokines) andImmunity 41, November 20, 2014 ª2014 Elsevier Inc. 695
Box 1. Diversity of Integrin Regulatory Machineries Critical for
Luminal Leukocyte-Endothelial Cell Interactions
Initial attachment of leukocytes to the luminal aspect of venu-
lar walls is mediated by a complex and highly diverse array of
signaling molecules that collectively translate apical chemo-
kine and/or chemoattractant signals transmitted to leukocyte
GPCRs into Gi-protein-mediated stimulation of multiple acti-
vating guanine exchange factors (GEFs). This can trigger
different Rho family GTPase members and Rap-1 GTPases
and their downstream effector molecules leading to confor-
mational integrin activation followed by the microclustering
of ligand-occupied integrins in numerous ventral focal points
(reviewed by [Herter and Zarbock, 2013]). Stimulated GPCRs
can also coactivate Rho and Rap-1 by triggering JAK PTKs
independently of Gi-protein activation (Montresor et al.,
2013). In some settings, the recruitment of the GPCR adaptor
b-arrestin might be critical for optimal integrin activation (Mol-
teni et al., 2009). Rho GTPases are thought to both directly
(Bolomini-Vittori et al., 2009) and indirectly activate talin-1 by
activating Rap-1 (Montresor et al., 2013). Importantly, different
GEFs regulate the multiple Rho GTPase activities critical for
leukocyte arrest and subsequent crawling and formation of
protrusions and the mode of action of these GEFs and their
GTPase targets varies with both the leukocyte type and
the composition of endothelial displayed trafficking signals
(Garcı´a-Bernal et al., 2006; Nombela-Arrieta et al., 2004; Shul-
man et al., 2006). Some of these GEFs can be regulated
by different PI3K- and DAG-dependent PKC isoforms. To
facilitate the high adhesion turnover required for crawling
and detachment of the leukocyte rear during breaching of
the endothelium, integrin function must be spatially and
negatively regulated by one or multiple mechanisms. This
includes a rapid return of integrin activating GTPases to
their inactive GDP-bound states, negative crosstalk between
coexpressed integrins (Porter and Hogg, 1997), activation of
Rho family GTPases that antagonize Rho and Rap integrin
activating activities (Bolomini-Vittori et al., 2009), and
myosin-II driven detachment forces of the uropod (Morin
et al., 2008). These signals can be counterinhibited by inhibi-
tory receptors such as neutrophil PILRa (Wang et al., 2013),
the TGF-b superfamily myeloid cell member GDF-15 (Kempf
et al., 2011), and GPCR agonists that suppress Gi signals
(Chigaev et al., 2008).
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cyte arrest (Lefort et al., 2012). Neutrophil rolling on endothelial
E-selectin engages the leukocyte PSGL-1 and assembles a
multicomponent signaling machinery that triggers establish-
ment of short lived and/or weak bonds between leukocyte in-
tegrins (e.g., LFA-1 and VLA-4) and their associated endothelial
cell ligands (e.g., ICAM-1 and VCAM-1), leading to slowing
down of selectin-mediated rolling [Block et al., 2012; Srira-
marao and Broide, 1996; Stadtmann et al., 2011; Zarbock
et al., 2008]). VAP-1, an ectoenzyme, induced at various sites
of inflammation, might also contribute to stabilization of rolling
via modifications of endothelial and leukocyte ligands (Jaakkola
et al., 2000).696 Immunity 41, November 20, 2014 ª2014 Elsevier Inc.Leukocyte arrest on endothelial cells of stimulated venules
requires activation of at least one of the major leukocyte integ-
rins, LFA-1 (all effector leukocytes) or Mac-1 (neutrophils and
monocytes), as well as VLA-4 and/or a4b7 (monocytes, eosino-
phils, and various effector T and B cells). This occurs by a strong
inside-out stimulatory signal, usually transmitted by chemoat-
tractant-mediated activation of G-protein-coupled receptors
(GPCRs) on rolling leukocytes (reviewed in [Alon and Feigelson,
2009; Dixit and Simon, 2012]). Lymphocyte arrest involves rapid
GPCR triggered activation of high-affinity integrin-ligand bonds
within focal adhesive contacts, postulated to consist of micro-
clusters of ligand-occupied integrins (Figure 1). These integrins
are initially bidirectionally stimulated within a fraction of a
second by coordinated cytoplasmic rearrangements of their
subunit tails and the binding of their own extracellular ligands
as mediated by primarily two cytoskeletal coactivators, the focal
adhesion proteins talin-1 and kindlin-3 (Lefort et al., 2012; Moser
et al., 2009; Ye et al., 2013). A subset of these focal contacts un-
dergo further adhesion, strengthening via recruitment of diffusive
integrins at distinct leukocyte compartments (Constantin et al.,
2000; Smith et al., 2005).
Post arrest, effector leukocytes either rapidly protrude and
translocate their body through the endothelial barrier, predomi-
nately at paracellular endothelial cell junctions, or use their integ-
rins to translocate (crawl) on the apical aspects of blood vessels
in search for exit cues (Phillipson et al., 2009) (Figure 1). In
most inflammatory settings, leukocyte crawling is both chemo-
kine-GPCR stimulated and integrin-dependent and is tightly
regulated by canonical actomyosin machineries serially trig-
gered by GPCR-activated small GTPases and integrin occu-
pancy events (Shulman et al., 2009) (Box 1). In vivo, intravascular
chemokine gradients have been postulated to provide a means
through which leukocytes are directed through healthy tissues
toward foci of sterile damage, thereby reducing potential collat-
eral damage of infiltrating effector leukocytes (McDonald et al.,
2010). As in other migratory processes, leukocytes reorganize
their actin cytoskeleton to generate a protrusive leading edge
and a contractile uropod (Hyun et al., 2012). Integrin recycling
to the leading edge of the leukocyte (Katagiri et al., 2006), as
well as polarized fusion of vesicles containing various signaling
molecules, might also contribute to directional leukocyte crawl-
ing toward venular exit sites.
During crawling, leukocytes generate numerous millipede-like
integrin-mediated contacts with the lumenal aspect of stimu-
lated vessels (Shulman et al., 2009) (Figure 1). Consequently,
physiological leukocyte crawling can persist also in opposite or
perpendicular to the direction of blood flow, allowing optimal
scanning capacity of the endothelial luminal surface (Carlin
et al., 2013; Phillipson et al., 2006; Sumagin et al., 2010). In
some settings, leukocytes bypass chemokine signals and
use their own integrins for activating leukocytes via integrin
outside-in signaling (Dixit et al., 2011; Jakus et al., 2009; Phillip-
son et al., 2009). Another modality of integrin activation, used by
subsets of neutrophils and monocytes involves TNF receptor
signaling on these leukocytes, as triggered by apically displayed
TNF (Sumagin et al., 2010; Woodfin et al., 2009). Endothelial-dis-
played TNF can activate adherent neutrophils directly via ampli-
fying integrin signaling or indirectly via promoting autocrine
chemokine and/or chemoattractant activation of the crawling
AB
Figure 2. Paracellular Leukocyte TEM
(A) Paracellular leukocyte migration through
endothelial cell junctions is the primary mode
through which leukocytes breach the endothelial
cell barrier in the peripheral vasculature (A). The
images are video micrographs of a stimulated
postcapillary venule of Lys-EGFP-ki mice (ex-
pressing green neutrophils & monocytes) in which
endothelial cell borders have been stained redwith
an anti-PECAM mAb. The left image illustrates
luminal leukocyte-venular wall interactions. The
right image, acquired in the red channel only,
shows intense PECAM-1 labeling of endothelial
cell contact points and also nonjunctional PECAM-
1-labeling that likely represents intracellular pools
of PECAM-1 (e.g., within the LBRC). Importantly,
the image shows micron-sized pores in PECAM-
labeled regions between adjacent endothelial cells
that represent sites of paracellular TEM.
(B) Paracellular TEM involves the coordinated
disassembly of VE-cadherin assemblies and of
other homophilic molecular interactions by serial
leukocyte occupancy events. ICAM-1, ICAM-2,
VCAM-1, and other CAM clustering events trans-
duce multiple outside-in signals, which involve
activation of endothelial Src and rise in cytosolic
free Ca2+. These events modulate numerous
endothelial targets, including cytoskeletal remod-
eling machineries that facilitate junction opening
and leukocyte crossing of endothelial cell junc-
tions. VE-cadherin internalization and recycling
are mediated by multiple tyrosine phosphorylation and dephosphorylation events temporally controlled by distinct endothelial sensors triggered by leukocyte
occupancy. Other endothelial cell border molecules can also be subjected to local proteolytic cleavage and changes in cytoskeletal anchorage states that further
facilitate their disassembly and transient internalization and recycling. Although the LBRCwas originally defined as a depot for PECAM-1, it is likely that additional
junctional adhesion molecules need to recycle between the endothelial surface and the LBRC, and other intracellular vesicles and VVOs. The cytoplasmic tails of
these multiple adhesion molecules might target the structures within which they are stored to fuse with the plasma membrane at specific endothelial com-
partments engaged by emigrating leukocytes. Some of these machineries might also be used for the relatively rare transcellular TEM route. These various
intracellular pools are distinct from vesicular stores of endothelial-produced chemokines that are tethered to submembranal actin filaments, as well as fromDARC
vesicles specialized to transcytose basolateral chemokines to the apical endothelial membrane. For simplicity, only representatives of key molecules expressed
between adjacent endothelial cells are shown without their counterparts on neighboring endothelial cells, and leukocyte integrins and CAMs are omitted.
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GPCR, integrin outside-in, and TNF machineries provides enor-
mous diversity and ensures robustness of leukocyte migration
on and through the endothelium (Box 1). These responses are
also tightly regulated by the relative density of available integrin
ligands, chemoattractants, and other endothelial displayed cyto-
kines and adhesive ligands encountered by the arrested and
crawling leukocytes (Shulman et al., 2012; Williams et al., 2011).
Breaching of the Endothelium
Multiple molecular and cellular events enable crawling leuko-
cytes to initiate breaching of the endothelium and exhibit trans-
endothelial cell migration (TEM). This includes detection of exit
cues that provide chemotactic and haptotactic guidance out of
the vascular lumen and beyond (see below), accurately timed
adhesive interactions with the luminal aspect of the endothelium,
and changes in leukocytemorphology that guide the large leuko-
cyte nucleus through tight endothelial junctions and pores. Such
responses generally coordinate the polarized movement of
leukocytes through endothelial cells in a luminal to abluminal di-
rection (Nourshargh et al., 2010). Leukocyte TEM can occur via
migration of leukocytes through junctions between adjacent
endothelial cells (paracellular TEM) or through the body of the
endothelium (transcellular TEM). In vitro and in vivo studies
have illustrated that TEM across stimulated endothelial cells of
the peripheral circulation is largely via the paracellular route(70%–90%) with transcellular TEM being a relatively low-fre-
quency event (Ley et al., 2007; Muller, 2011; Woodfin et al.,
2011) (Figure 2). Brain vascular endothelial cells seem to be an
exception to this rule as they support a higher proportion of
transcellular leukocyte TEM, a phenomenon that has been attrib-
uted to the specialized tight junctional structures expressed by
brain endothelial cells that can restrict paracellular TEM (Engel-
hardt and Ransohoff, 2012).
Both paracellular and transcellular modes of TEM are sup-
ported by leukocyte-driven molecular changes in the endo-
thelium. For example, integrin-mediated leukocyte adhesion
can trigger clustering of endothelial ICAM-1, and concomitant
recruitment of VCAM-1 into membranous structures that provide
platforms for stable leukocyte firm arrest and TEM (Barreiro
et al., 2008; Carman and Springer, 2004). Ligation of ICAM-1
and VCAM-1, and their tetraspannin or pentaspanin partners
(e.g., CD9, CD151 or CD47, respectively) (Azcutia et al., 2012),
by adherent and crawling leukocytes can also elicit multiple
signaling events in endothelial cells postulated to reduce endo-
thelial barrier properties (Figure 2). This includes increased intra-
cellular Ca2+ (Huang et al., 1993; Pfau et al., 1995), reactive
oxygen species (ROS) generation (Deem et al., 2007; Martinelli
et al., 2009), and activation of p38 mitogen-activated protein ki-
nase (MAPK) (Hu et al., 2000). In addition, ICAM-1 ligation can
result in tyrosine phosphorylation of key endothelial cell junc-
tional molecules through activation of endothelial proline-richImmunity 41, November 20, 2014 ª2014 Elsevier Inc. 697
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Reviewtyrosine kinase 2 (Pyk2) and Src kinase (Allingham et al., 2007).
These responses can couple to the triggering of RhoA (a small
GTPase involved in regulation of actin cytoskeletal networks)
and its downstream Rho-associated protein kinase (ROCK), as
well as to endothelial myosin light-chain kinase (Saito et al.,
2002). ICAM-1 occupancy by leukocytes can also lead to the
translocation of clustered ICAM-1 to actin- and caveola-rich do-
mains that recruits vesiculovacuolar organelles (VVOs) to form
intracellular channels through which leukocytes can breach
endothelial cells via a transcellular pore (Carman et al., 2007;
Milla´n et al., 2006).
Once leukocytes have engaged with endothelial cell junctions,
breaching of the endothelium is exquisitely regulated by adhe-
sion molecules expressed selectively, or at high density, be-
tween adjacent endothelial cells (Figure 2). Two key junctional
structures are adherens junctions that include VE-cadherin,
and tight junctions that incorporate members of the junctional
adhesion molecule (JAM) family (e.g., JAM-A, JAM-B, JAM-C,
and endothelial cell-selective adhesion molecule [ESAM]) and
claudins (Dejana, 2004). A number of other adhesion molecules
are also enriched at borders of adjacent endothelial cells, such
as PECAM-1, CD99, ICAM-2, and the polio virus receptor
(PVR) (Muller, 2011; Nourshargh et al., 2010). The roles of these
multiple molecules and their respective leukocyte ligands in
leukocyte TEM are well established, but most probably vary for
different leukocytes, different venules, and inflammatory models
(reviewed by [Ley et al., 2007; Muller, 2011; Nourshargh et al.,
2010; Vestweber, 2012; Voisin and Nourshargh, 2013]).
Intriguingly, expression of endothelial cell border adhesion
molecules can be temporally and spatially regulated by inflam-
matory stimuli and TEM (Figure 2) (Muller, 2011; Voisin and Nour-
shargh, 2013). Such molecular reorganization of the endothelial
cell contact points can play key roles in regulation of vascular
permeability tomacromolecules and leukocyte TEM (Vestweber,
2012). Leukocyte TEM in itself can affect the cell surface
redistribution and internalization of key cell border structures,
the recycling of intracellular pools of these molecules and their
enzymatic cleavage (reviewed by [Ley et al., 2007; Muller,
2011; Vestweber, 2012; Voisin and Nourshargh, 2013]). Notably,
multiple junctional endothelial cell adhesion molecules are
thought to recycle in a variety of intracellular compartments
and/or vesicles including the membranous lateral border recy-
cling compartment (LBRC), endosomes, and possibly VVOs (re-
viewed by [Ley et al., 2007; Muller, 2011; Vestweber, 2012]).
Although relatively little is known about these intracellular pools
in terms of their potential crosstalk and regulation by leukocyte
occupancy, they appear to contribute tomaintaining the integrity
of the endothelium and to provide new membranous pools that
surround the leukocyte as it passes across endothelial cells
(Mamdouh et al., 2003). For example, the LBRC acts as a depot
for molecules such as PECAM-1, CD99, JAM-A, and PVR and
supports leukocyte TEM through efficient recruitment of key
molecules to sites of leukocyte diapedesis (Muller, 2011)
(Figure 2). This structure although primarily implicated in paracel-
lular leukocyte TEM has also been associated with transcellular
leukocyte TEM (Mamdouh et al., 2009). The precise endothelial
signals that stimulate LBRC and other vesicle trafficking and
recycling are still unclear but might involve Src kinase activities
(reviewed by [Muller, 2011]). Better understanding of the spatio-698 Immunity 41, November 20, 2014 ª2014 Elsevier Inc.temporal distribution and function of individual endothelial cell
border moleculesmight help identify previously unknown regula-
tory pathways involved in the onset and resolution of leukocyte
trafficking.
Successful paracellular leukocyte TEM also depends on a
transient loss of cell-surface VE-cadherin (Weber et al., 2007).
VE-cadherin plays a critical role in maintaining the integrity of
endothelial cell contacts via homotypic associations between
neighboring endothelial cells, as well as maintaining the barrier
function of the endothelium to macromolecules and emigrating
leukocytes (Vestweber, 2012). These numerous functions of
VE-cadherin are regulated by multiple cytoplasmic catenins
that control the functional interaction between VE-cadherin
and the cortical actin endothelial cytoskeleton (reviewed by
[Weber et al., 2007]). VE-cadherin is also constitutively associ-
ated with a specialized phosphatase, VE-PTP, that needs to
dissociate from its neighbor VE-cadherin complex in response
to leukocyte occupancy (Vockel and Vestweber, 2013). This pro-
motes tyrosine phosphorylation events of both VE-cadherin and
its associated catenins (Broermann et al., 2011), while a distinct
SHP-2-dependent tyrosine dephosphorylation event recruits the
endocytic adaptor a-adaptin to drive a reversible endocytosis of
VE-cadherin in close vicinity of adherent leukocytes (Wessel
et al., 2014). Indeed, leukocyte diapedesis is strongly sup-
pressed in vivo in several mice models genetically perturbed in
VE-cadherin endocytosis and turnover (Broermann et al., 2011;
Vestweber, 2012). VE-cadherin endocytosis is not triggered by
ICAM-1- or VCAM-1-occupancy events and is therefore mecha-
nistically distinct from the numerous ICAM-1 and VCAM-1
transduced signaling events discussed above. Of importance,
leukocyte TEM and increased endothelial permeability to solutes
are mediated by two distinct phosphorylation states of VE-
cadherin (Wessel et al., 2014). Although a gatekeeper of para-
cellular endothelial junctions, VE-cadherin is dispensable for
transcellular leukocyte TEM.
Breaching Venular Walls Post Transendothelial Cell
Migration
To fully exit venular walls, leukocytes that have penetrated the
endothelial cell barrier are subsequently required to cross the
pericyte sheath and the venular basement membrane (BM) (re-
viewed by [Nourshargh et al., 2010]). Pericytes are mural cells
that form the second cellular component of all venules and are
typically found in a discontinuous manner wrapped around
endothelial cells and embedded within the venular BM (Armulik
et al., 2005; Nourshargh et al., 2010). While pericytes have long
been considered as important players in vascular development
and function (Armulik et al., 2005), there is now a growing body
of evidence highlighting the significance of these cells as regula-
tors of immune responses and inflammation and interpreters
of danger signals (reviewed by [Nourshargh et al., 2010; Pober
and Tellides, 2012; Voisin and Nourshargh, 2013], Figures 1
and 3). Specifically, pericytes can inducibly express key adhe-
sion molecules (e.g., ICAM-1, VCAM-1), chemokines (e.g.,
human and murine CXCL1, CXCL8, MIF), and receptors for
proinflammatory molecules (TNFRI, TNFRII, IL-1R, TLRs, Nod-
like receptors) (Pober and Tellides, 2012; Stark et al., 2013; Voi-
sin andNourshargh, 2013). In vitro, pericyte-expressed adhesion
molecules and chemokines support leukocyte attachment,
AB
Figure 3. Establishment of Exit Cues for Leukocytes Breaching Venular Walls
Multiple mechanisms support the efficient migration of leukocytes through endothelial cells, the venular BM, and the pericyte layer. This includes preferential sites
of migration and the establishment of chemotactic and haptotactic gradients that translate initial leukocyte protrusions into a stable leading edge. The confocal
images shown in (A), acquired from fluorescently-labeled stimulated mouse cremaster venules, demonstrate the existence of low protein deposition regions
within the laminin-511 network of the venular BM (left panel). These regions (termed LERs) are alignedwith gaps in the pericyte sheath (middle panel) and are used
by emigrating leukocytes preferentially to breach the venular wall (right panel). In addition, components of the vasculature, perivascular cells, and possibly
migrating leukocytes themselves can generate series of chemotactic signals to support a directional luminal-to-abluminal leukocyte transmigration response (B).
This includes endothelial-cell-derived chemotacticmolecules aswell as proinflammatory and promigratory signals released by pericytes, perivascular leukocytes
(macrophages and mast cells), and recently emigrated leukocytes. Soluble and GAG-immobilized chemokines recognized by leukocyte GPCRs (B, inset) can
cooperatively guide emigrating leukocytes out of the vasculature. Loss of net attractant cues might result in disrupted directional motility of leukocytes. Pericyte
chemokines and cytokines (not shown) can also guide and instruct emigrating leukocytes with costimulatory and possibly prosurvival signals. Emigrating leu-
kocytes can also use their b2 integrins (not shown) to migrate on both the abluminal endothelial aspects and on pericytes expressing ICAM-1 (inset) and get
instruction signals of costimulation and survival. Lymphocyte b2 integrins might be alternatively triggered by local cognate antigen-driven signals presented by
perivascular macrophages (not shown). In some settings, leukocyte b1 integrins can recognize specific ECM ligandswithin the basement membrane (not shown).
Further details are described in the text.
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Pober and Tellides, 2012; Stark et al., 2013; Voisin and Nour-
shargh, 2013). A large variation in the profile of pericyte-leuko-
cyte communications has been reported, very likely due to the
heterogeneity of pericytic cells from different blood vessels,
tissues, species, isolation procedures, and inflammatory set-
tings. The relevance of such interactions to leukocyte trafficking
in vivo is only just beginning to emerge (Voisin and Nourshargh,
2013). The application of confocal intravital microscopy to anal-
ysis of neutrophil-pericyte interactions within cytokine-stimu-
latedmouse cremastermuscles identified a key role for pericytes
in subendothelial cell neutrophil motility (Proebstl et al., 2012).
Specifically, pericytes were observed to provide an adhesive
substrate for neutrophils crawling within the venular wall andseeking portals to the extravascular tissue (Proebstl et al.,
2012) (Figure 3). This response was mediated through the inter-
action of pericyte-expressed ICAM-1 with neutrophil Mac-1 and
LFA-1. Of relevance, the use of an endothelial cell pericyte
in vitro coculture model indicated that the TEM process itself
can prime neutrophils for enhanced interactions with pericytes
(Ayres-Sander et al., 2013). Adhesion of fully extravasated
myeloid cells with the abluminal aspect of pericytes has also
been proposed as a mechanism through which various leuko-
cyte effector functions are enhanced by specific instructing sig-
nals presented by subsets of inflamed pericytes (Stark et al.,
2013). Collectively, pericytes appear to fine-tune leukocyte traf-
ficking and instruct emigrated leukocytes for optimized naviga-
tion and effector responses at sites of inflammation. The impactImmunity 41, November 20, 2014 ª2014 Elsevier Inc. 699
Box 2. Regulatory Roles of Perivascular Mast Cells in Leukocyte
Diapedesis
Along with tissue-resident macrophages, mast cells are the
prototypical tissue-resident immune sentinels that reside in
most peripheral tissues, often in close vicinity of arterioles, ve-
nules and postcapillary venules (Duffy et al., 2012; Kunder
et al., 2011). These granule rich cells store a multitude of in-
flammatory (e.g., inflammatory cytokines, myeloid-attracting
chemokines) and vasoactive mediators (e.g., histamine, pros-
taglandins, leukotrienes, and thromboxanes), critical for trig-
gering the onset of acute and chronic inflammatory reactions
(Abraham and St John, 2010). Mast cell secretion is tightly
regulated by a variety of inflammatory and stress signals,
including tissue damage, microbial infections and the binding
of allergen-coated crosslinked immunoglobulin E to their FcRe
receptors (Cheng et al., 2013). During acute allergic re-
sponses, infection, and injury, mast cell degranulation results
in immediate (type I) endothelial upregulation of endothelial
stored P-selectin and rapid PAF synthesis critical for early
neutrophil recruitment and extravasation (Lorant et al., 1991;
Ostrovsky et al., 1998). Of interest, mast cells have been
shown to act cooperatively with tissuemacrophages to recruit
neutrophils in response to LPS, with TLR stimulation providing
rapid neutrophil recruitment via release of preformed CXC
chemokines nearby vessels followed by slower macrophage-
mediated recruitment of the leukocytes deeper into the extra-
vascular tissue (De Filippo et al., 2013). Despite such studies
and the clear potential role of mast cells in inflammation,
further investigations are required to fully elucidate the func-
tions of these versatile sentinel cells in leukocyte trafficking.
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morphology, and immune responses of both cell types requires
further investigations.
Like their endothelial cell counterparts, pericytes contribute to
the generation and barrier properties of the venular BM. The ven-
ular BM is composed of a complex network of laminins (primarily
isoforms 411 and 511) and collagen IV, interconnected by
molecular bridges involving numerous other glycosaminoglycan
(GAG)-decorated glycoproteins such as nidogens and perlecan
(Sorokin, 2010). This structure provides a formidable barrier to
emigrating cells, but the mechanism through which leukocytes
breach the venular BM is not fully understood (Rowe and Weiss,
2008). Proteolytic cleavage of BM constituents by emigrating
leukocytes has long been considered as a possible mechanism,
because it has been implicated in cancer cell invasiveness and
intravasation (Sabeh et al., 2009). However, the physiological im-
plications of degrading a structure that is key to maintaining
vascular integrity renders this option unlikely and indeed conten-
tious (Rowe and Weiss, 2008). A more plausible mechanism is
the potential existence of leukocyte-permissive regions within
the venular BM. In this context, immunofluorescent studies
have demonstrated the existence of regions within the venular
BM that exhibit low deposition of certain matrix proteins (lami-
nin-511 and type IV collagen) (Voisin and Nourshargh, 2013; Voi-
sin et al., 2010; Wang et al., 2006) (see Figure 3). These sites,
which have been termed low-expression regions (LERs), consti-700 Immunity 41, November 20, 2014 ª2014 Elsevier Inc.tutively exist in all vascular beds analyzed and are commonly
directly alignedwith gaps between adjacent pericytes, indicating
the importance of pericytes in generation of BM constituents. As
predicted by their permissive nature, LERs act as ‘‘gates’’ for
transmigrating neutrophils and monocytes in vivo (Voisin and
Nourshargh, 2013; Voisin et al., 2010; Voisin et al., 2009; Wang
et al., 2006). Interestingly, LERs are transiently enlarged during
neutrophil transmigration through subtle disassembly and phys-
ical carriage of neutrophil-bound BM components, most notably
laminins (Voisin et al., 2010; Voisin et al., 2009; Wang et al.,
2006). Such molecular remodeling might be facilitated by leuko-
cyte adhesion to the venular BM as numerous studies have indi-
cated roles for b1 integrin laminin receptors a6b1 and a3b1 in
neutrophil migration through the venular BM (Dangerfield et al.,
2002; Hyun et al., 2012). Other mechanisms that could
contribute to leukocyte migration include possible ‘‘thinning’’ of
the BM as caused by tractional forces exerted on the matrix net-
works by pericyte shape-change (Finsterbusch et al., 2014; Pro-
ebstl et al., 2012) or other physical and enzymatic processes
(Rowe and Weiss, 2008). In addition, subunits of laminins with
lower capacity for crosslinking with collagen type IV molecules
(e.g., the short a4 chain of laminin-411) might provide more
penetrable LERs due to easier dissociation of the laminin and
collagen IV networks during cell migration.
Exit Cues for Leukocyte Transmigration
The contribution of chemokines and other chemoattractants for
distinct steps of leukocyte TEM has been extensively studied
both in vitro (reviewed by [Shulman and Alon, 2012]) and in vivo
(reviewed by [Blanchet et al., 2012; Ingersoll et al., 2011]). While
endothelial cells are accepted as a major source of chemotactic
molecules for effector leukocytes, pericytes (Proebstl et al.,
2012), fragments of the venular BM, perivascular macrophages
(Abtin et al., 2014), certain subsets of mast cells (see Box 2), anti-
genic signals (Box 3), and recently extravasated leukocytes are
postulated to also send short-range guidance cues for transmi-
grating leukocytes.
Type II protein synthesis-dependent activation of endothelial
cells can result in the expression of a variety of chemoattractants
for myeloid leukocytes and effector T cells (Pober and Sessa,
2007). Chemokines constitute a key component of the repertoire
of endothelial cell-derived exit cues and the expression of these
molecules on the endothelium is regulated by numerous modes,
most notably via binding to heparin sulfate (HS) glycosaminogly-
cans (GAGs) (Proudfoot, 2006). These largeGAGs decorate a va-
riety of membranous and extracellular matrix proteins and can
serve as chemokine scaffolds in multiple types of interstitial
spaces (Sarris et al., 2012), as well as different types of blood
vessels and lymphatics (Bao et al., 2010; Wang et al., 2005;
Weber et al., 2013). A recent study suggests that blood vessels
both in lymphoid and nonlymphoid tissues pattern steep gradi-
ents of HS scaffolds between their luminal and basolateral endo-
thelial aspects (Stoler-Barak et al., 2014). The enriched HSGAGs
might be necessary to maintain functional chemokine gradients
toward the basolateral aspects of blood vessels. Indeed, excess
deposition of the HS binding chemokine CXCL1 on apical as-
pects of inflamed blood vessels results in reduced neutrophil
diapedesis (Yao et al., 2013). Of note, HS or other GAGs do
not appear to be essential for all types of inflammatory reactions
Box 3. A Role for Antigenic Signals in T Cell Diapedesis and
Retention in Tissues
In the context of the adaptive immune response, the migratory
patterns acquired by antigen-experienced effector T lympho-
cytes that egress lymphoid organs and migrate to affected
tissues are still not fully elucidated (Agace, 2006). In addition
to upregulating selectin ligands and integrins, as well as
GPCRs for multiple inflammatory chemokines (Reinhardt
et al., 2003; Weninger et al., 2001), these T cells likely undergo
tissue-restricted imprinting of specific trafficking molecules
depending on the organ they were generated in (Woodland
and Kohlmeier, 2009). A long-standing question is whether
and when antigenic signals presented to these effector
T cells and their memory counterparts by the vasculature at
the site of infection or inflammation also contribute to the
recruitment of these lymphocyte subsets (Marelli-Berg and
Jarmin, 2004; Pober et al., 2001). Apical presentation of
cognate antigenic peptides by endothelial MHC-I and perivas-
cular DCs might potentially augment integrin adhesiveness
and diapedesis of CD8 subsets, especially within vascular
beds deficient in adhesive and chemotactic activities (Savinov
et al., 2003;Walch et al., 2013). Antigen-specific CD4 effectors
can use cognate antigen-driven signals presented by MHC-II
for entry into pancreatic islets in early stages ofmouse autoim-
mune diabetes (Calderon et al., 2011) and extravasating CD4
T cells can readily interact with antigenic moieties presented
by perivascular macrophages at various chronic sites of
inflammation (Bartholoma¨us et al., 2009). It is likely, however,
that such vascular and perivascular antigenic signals recog-
nized by cognate effector T cells contribute to their emigration
only when the expression of vascular and perivascular traf-
ficking signals become limited.
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peptides, and C5a lack affinity for GAGs (Goodarzi et al., 2003).
As well as generating chemokines, endothelial cells can actively
import chemokines produced by perivascular cells by various
transcytosis machineries (Middleton et al., 1997). The atypical
GPCR like molecule DARC (Duffy antigen) displays promiscuous
affinity for most CXC chemokines and inflammatory CC chemo-
kines (reviewed by [Mantovani et al., 2006]) and plays amajor but
probably not an exclusive role in both the transcytosis of perivas-
cular chemokines and their correct positioning on the apical
surface of the endothelium (Middleton et al., 1997) (Figure 2).
Interestingly, DARC-mediated transcytosis of chemokines to
the apical aspect of endothelial cells is also HS dependent (Mid-
dleton et al., 1997; Wang et al., 2005). The key role of DARC in
chemokine transcytosis is supported by its expression profile,
recently found to be restricted to postcapillary venules (U. von
Andrian, personal communication).
Other vascular-derived sources of chemotactic cues are peri-
cytes and the vascular BM (Figure 3). As discussed above, peri-
cytes can generate chemokines and immobilize them on GAGs
(Stramm et al., 1987). Conceptually, the generation of pericyte-
derived chemokines and/or chemokine depots is likely to play
a key role in facilitating continued migration of leukocytes
through venular walls after the breaching of the endothelium.The constitutive existence of the venular BM LERs might also
provide a mechanism through which guidance molecules gener-
ated in the extravascular tissue, or released from perivascular
macrophages or mast cells, penetrate the venular wall and
hence create a chemotactic gradient toward these preferential
vascular exit sites. Thus, multiple mechanisms enable vascular
and perivascular components to cooperatively guide the pas-
sage of leukocytes from the vascular lumen to the extravascular
tissue. This includes the release of proinflammatory mediators
and chemotactic molecules from extravasated or tissue-resident
leukocytes. Specifically, because blood leukocytes are a rich
source of preformed granular chemoattractants, such as
cathepsin G, LL-37, and azurocidin (Borregaard et al., 2007;
Soehnlein et al., 2008), and can also release lipid and protein
chemotactic molecules (e.g., LTB4, PAF, and various chemo-
kines), recently extravasated myeloid leukocytes might further
stimulate leukocyte recruitment via a relay phenomenon, typi-
cally observed in interstitial spaces (Afonso et al., 2012; La¨mmer-
mann et al., 2013). With respect to tissue-resident leukocytes
(Figure 3; Box 2), in infectious models, neutrophils extravasate
from inflamed dermal venules in close proximity to perivascular
macrophages and mast cells that produce large amounts of
both neutrophil and monocyte attracting chemoattractants
(e.g., CXCL1, CXCL2, and CCL2) (Abtin et al., 2014; De Filippo
et al., 2013). The repertoire of perivascular macrophages
and mast cells is highly versatile with different subsets of these
cells generating different profiles of inflammatory mediators
in response to distinct danger signals (Figure 1) (Galli et al.,
2011). Notably, later on during the inflammatory process, extrav-
asating neutrophils phagocytosed by perivascular macro-
phages can negatively regulate further leukocyte extravasation
by secreting a variety of resolution mediators such as resolvins,
lipoxins (Wolf et al., 2008), TGF-b, and IL-10. These mediators
can directly reduce leukocyte adhesion and responsiveness to
chemoattractants, as well as attenuate endothelial expression
of trafficking molecules (reviewed by [Soehnlein et al., 2009]).
MMPs secreted from perivascular macrophages might also
contribute to this resolution by cleaving chemokines (Wolf
et al., 2008).
Aberrant Modes of Leukocyte Extravasation
A number of aberrant modes of leukocyte extravasation, at
odds with the well-described sequence of molecular and
cellular responses described by the classical leukocyte-adhe-
sion cascade, have also been reported. As discussed, leukocyte
crawling on the luminal aspect of the endothelium represents a
key phase of the leukocyte-adhesion cascade that enables leu-
kocytes to seek exit cues and preferential sites of leukocyte
migration within the venular wall. Nevertheless, in certain nonin-
flammatory settings, leukocyte crawling is not followed by
emigration into tissues because it is mainly used for patrolling
for intravascular signs of injury or infection (Auffray et al., 2007;
Carlin et al., 2013). Specifically, Ly6Clo monocytes comprise a
noninflammatory subset of monocytes that crawl at steady state,
exhibiting long-range luminal lateral migration responses, within
blood vessels of noninflamed tissues (Auffray et al., 2007; Carlin
et al., 2013). This response is supported by basally expressed
ICAM-1 and ICAM-2 and constitutively adhesive LFA-1 ex-
pressed by the crawling subset of monocytes (Carlin et al.,Immunity 41, November 20, 2014 ª2014 Elsevier Inc. 701
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depend on a prior stimulation by a P-selectin-mediated rolling
phase and does not require chemokine signals (Carlin et al.,
2013). Furthermore, while patrolling small blood vessels in
various organs (e.g., skin, kidney), and reportedly scavenging
luminal endothelial microparticles as part of their tissue surveil-
lance functions, these monocytes appear to recruit neutrophils
upon encounter of stimuli, but rarely breach venular walls them-
selves (Carlin et al., 2013). Abortive emigration of leukocytes to
blood vessels is observed in other settings including natural killer
(NK) and NKT cell crawling inside liver sinusoids (Geissmann
et al., 2005) and retention of immature B cells in the bone-
marrow vasculature (Pereira et al., 2009). These and other forms
of leukocyte-vessel wall interactions that are futile in terms of
breaching the vessel wall could comprise an important range
of essential physiological homeostatic leukocyte surveillance
responses, important in leukocyte survival, differentiation, or re-
programming by organ-specific intraluminal vascular signals.
Leukocyte-vessel wall interactions without the need for extrava-
sation might also regulate vascular permeability through luminal
release of leukocyte-derived vasoactive factors such as TNF
(Finsterbusch et al., 2014) or via signaling to endothelial cells
after ligation of key adhesion molecules such as ICAM-1 (Suma-
gin et al., 2011).
Unsuccessful breaching of vessel walls could also constitute
pathological forms of leukocyte-vessel wall interactions as
a result of excessive intraluminal leukocyte activation. Such
responses can typically cause vascular injury through release
of damaging neutrophil-derived factors (e.g., ROS, proteases),
as exemplified by FcgRIIIB-triggered b2 integrin-dependent
neutrophil arrest following immune-complex deposition on
resting blood vessels (Mayadas et al., 2009). Of interest, multi-
photon intravital microscopy has additionally illustrated that in
noninflamed murine kidneys, neutrophils and monocytes are
commonly retained in glomerular capillaries (static or crawling)
and that the duration of this phenomenon is enhanced after im-
mune-complex-elicited glomerular injury (Devi et al., 2013). Intra-
vascular activation can also occur following severe sepsis, a
condition during which live neutrophils can release neutrophil
extracellular traps (NETs) within the vascular lumen while main-
taining some irregular crawling responses (McDonald et al.,
2012).
While leukocyte migration through endothelial cells commonly
occurs in a luminal-to-abluminal direction, there is now unequiv-
ocal evidence for the occurrence of TEM in the basal to apical di-
rection of the endothelium. This leukocyte reverse TEM (rTEM)
response has been reported for human monocyte, neutrophil,
and T cell migration through cultured endothelial cells (Buckley
et al., 2006; Lee et al., 2009; Randolph and Furie, 1996) and for
neutrophils in zebra fish embryos (Mathias et al., 2006). Neutro-
phil rTEM, and a TEM mode that involves multiple oscillatory
movements within endothelial cell junctions (termed ‘‘hesitant’’
TEM), have also been observed in stimulatedmouse cremasteric
venules in vivo (Woodfin et al., 2011). Of importance, these
events were totally localized to the endothelium, and leukocytes
that had breached the pericyte and venular BM layer were never
seen to exhibit reverse motility back into the vascular lumen.
Neutrophil and monocyte rTEM is significantly enhanced under
conditions of reduced expression and/or functionality of endo-702 Immunity 41, November 20, 2014 ª2014 Elsevier Inc.thelial cell JAM-C (Bradfield et al., 2007; Woodfin et al., 2011),
suggesting that JAM-C plays a key role in regulating the direc-
tional movement of leukocytes from the apical to basal aspect
of the endothelium. The underlying mechanism of leukocyte
rTEM is at present unclear but might involve disruption of local
organization of exit cues, existence of competing gradients of
chemoattractants and repellents, and/or desensitization of
leukocyte GPCRs following high-receptor occupancy (Hutten-
locher and Poznansky, 2008). Leukocyte migration into the
vascular lumen can be physiologically important, such as
encountered during trafficking of leukocytes from the bone
marrow to the vasculature as part of leucocytosis and during
lymphocyte migration from lymphoid tissues to the vascular
compartment as part of immune surveillance (Huttenlocher and
Poznansky, 2008). However, the functional role of this response
within inflammatory scenarios remains unclear and requires
further investigations. Interestingly, neutrophil rTEM following
ischemia-reperfusion injury has been associated with dissemi-
nation of systemic inflammation (Woodfin et al., 2011), and
rTEMcould be involved in dissemination of pathogens from a pri-
mary site of infection to distant organs (Duffy et al., 2012).
Furthermore, based on findings in zebra fish embryos where
neutrophils have been seen to migrate away from the site of
injury, leukocyte reverse motility has also been proposed as a
means of resolving an inflammatory response (Deng and Hutten-
locher, 2012).
Finally, important examples of aberrant modes of leukocyte
trafficking relate to tissue-specific responses, in line with the
specialized vascular morphology and/or rheological properties
of certain organs such as the lungs, liver, and the brain (Engel-
hardt and Ransohoff, 2012; Lee and Kubes, 2008). Most
notably, neutrophil migration into the lung parenchyma is
selectin- and b2-integrin-independent where adhesion and
TEM occurs in the absence of rolling in pulmonary capillaries (re-
viewed by [Doerschuk, 2001]). Furthermore, in the liver, blood
drains through sinusoids, which are capillary-like vessels that ex-
press a unique type of endothelium that is discontinuous and
fenestrated, lacking basal lamina and tight junctions (Jenne
and Kubes, 2013). Liver sinusoidal endothelial cells also lack
the capacity to express E- and P-selectins, and in line with
this, leukocyte adhesion within sinusoids appears to occur inde-
pendently of rolling. In addition, sinusoidal endothelial cells ex-
press low inducible expression of VCAM-1 but high constitutive
expression of ICAM-1 and, most notably, of the adhesion mole-
cule VAP-1 (Salmi and Jalkanen, 2001) and the CD44 ligand,
hyaluronan (McDonald et al., 2008). Collectively, there is ample
evidence to support the concept that organ-specific anatomical,
cellular, molecular, and hemodynamic features are critical for
mediating specific leukocyte trafficking responses in line with
the specialized immune-surveillance requirements and functions
of different organs.
Concluding Remarks and Future Perspectives
While the identity of key molecular and cellular players involved
in orchestrating an effective leukocyte trafficking reaction is
well established, there remains a need for better understanding
of the intricacies, dynamics, cellular interplays, and diversities
of this critical immune response. In this context, advancements
in versatile imaging modalities have dramatically enhanced our
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and vessel types and in an organ-specific manner. In addition
to building on these fundamental issues, a number of specific
avenues not discussed in the present review also require further
explorations. These include a better understanding of the impact
and regulatory effects of the neuronal and the endocrine system
on both vascular components and leukocytes. For example,
almost all blood vessels are intimately associated with peripheral
nerves, and at present it is unclear whether and how neuro-
transmitters affect leukocyte extravasation to peripheral and
lymphoid tissues in homeostasis and inflammation. Further-
more, although there is much evidence for different susceptibil-
ities of men and women to infections and inflammatory diseases
(reviewed by [Libert et al., 2010]), the underlying molecular basis
of this gender-difference on leukocyte trafficking and leukocyte-
vessel-wall crosstalk remains unclear. Similarly, despite much
interest in the impact of circadian rhythm on inflammatory
responses (reviewed by [Scheiermann et al., 2013]), it remains
unclear whether and how different endothelial cells, and their
associated pericytes, are subjected to circadian modulation of
transcription and how this impacts trafficking and recruitment
of different leukocyte subsets during different times of the day.
In recent years, the impact of aging on vascular morphology
has received much attention, but there remains a paucity of
understanding of whether and how vascular senescence im-
pacts leukocyte-vessel-wall interactions. Other open questions
include the variation of blood vessel glycocalyx and basement
membrane composition between different organs and inflamma-
tory conditions. In this regard, the pulmonary vasculature has
been shown to contain a particularly thick HS stabilized glycoca-
lyx believed to mask endothelial-expressed adhesion molecules
including integrin ligands frommarginating leukocytes before it is
degraded by inflammatory signals (Schmidt et al., 2012). Never-
theless, similarmasking functions have not been attributed to the
glycocalyx of venules. Likewise, differing composition and bar-
rier properties of distinct basement membranes might result in
different subsets of leukocytes using different venular breaching
strategies to extravasate these distinct perivascular barriers.
Experimentally, in spite of the increasing use of genetically
modified mouse models in leukocyte trafficking studies, it is
not yet possible to use similar models for silencing key endothe-
lial and pericyte machineries involved in leukocyte trafficking,
due to the high toxicity of such systemic genetic approaches.
As a result, there is a growing need to not only temporally silence
genes of interest in blood-vessel-wall cells, using newly devel-
oped conditional and cell-type recombinase-based targeting
approaches, but also restrict the temporal gene silencing to a
confined subset of vessels.
In summary, leukocytes are provided with a diverse range of
highly versatile and selective options in responding to different
molecular cues in breaching blood vessel walls at different
sites of inflammation. The studies reviewed here highlight
considerable heterogeneity in vessel-wall composition, resulting
in extremely large combinatorial range of trafficking signals
and endothelial barrier regulatory molecules that shape leuko-
cyte recruitment and activation in distinct tissues. The assort-
ment of vascular trafficking molecules discussed, and the
large combinatorial diversity they provide, introduce new chal-
lenges to the future design of composite antimigration therapiesand their implementations for personalized anti-inflammatory
medicine.
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